Page last updated: 2024-09-04

1,2-di-o-tetradecyl-3-o-(glucopyranosyl)glycerol and Gaucher Disease

1,2-di-o-tetradecyl-3-o-(glucopyranosyl)glycerol has been researched along with Gaucher Disease in 1 studies

*Gaucher Disease: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devraj, RV; Diven, WF; Glew, RH; Gopalan, V; Hubbell, CA; Lawson, RA; Mannock, DA1

Other Studies

1 other study(ies) available for 1,2-di-o-tetradecyl-3-o-(glucopyranosyl)glycerol and Gaucher Disease

ArticleYear
2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
    The Biochemical journal, 1991, Mar-01, Volume: 274 ( Pt 2)

    Topics: beta-Glucosidase; Binding, Competitive; Brain; Calorimetry; Computer Simulation; Female; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Glycolipids; Humans; Kinetics; Molecular Conformation; Placenta; Pregnancy; Reference Values; Spleen; Substrate Specificity

1991